Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Jayant Bhandari: Contrarian View on Western Virtues, Junior Mining, Precious Metals

Jayant Bhandari the founder of Capitalism and Morality sits down with Maurice Jackson to provide contrarian views on the virtues of western civilization, junior mining opportunities, and the value proposition of physical precious metals. Mr. Bhandari is one of the most...
Maurice Jackson | January 7, 2020 |

Two Views of Yesterday’s Gold Strength

The great day of the Fed interest rates decision and forward guidance has arrived. There hasn’t been much pre-positioning volatility in the precious markets so far. With the exception of gold perhaps, you might say. Let’s dive in and assess whet...
Przemyslaw Radomski, CFA | July 31, 2019 |

Biopharma Buys 'Insurance Policy Ahead of First Commercial Launch'

The terms of the financial transaction and the potential reasons for it are discussed in a BTIG report. In a June 26 research note, BTIG analyst Thomas Shrader reported that Esperion Therapeutics Inc. (ESPR:NASDAQ) agreed to an "up to $200 capped, tier...
Streetwise Reports | July 3, 2019 |

Lithium Firm's Deposits Show High-Purity Spodumene

The implications of the results and the next catalyst are addressed in a ROTH Capital Partners report. In a June 19 research note, ROTH Capital Partners analyst Joe Reagor reported that mineralogical testing of Piedmont Lithium Ltd.'s (PLL:NASDAQ; PLL:A...
Streetwise Reports | June 25, 2019 |

STACK Agreement 'Positive' for Area Operator

The deal details are relayed in a ROTH Capital Partners report. In a Dec. 10 research note, ROTH Capital Partners analyst John White purported that a recent development in the industry is positive for Chaparral Energy Inc. (CHAP:NYSE) as its primary areas of operati...
Streetwise Reports | December 13, 2019 |

U.S. Biotech Makes 'The Acquisition We Were Waiting For'

By tucking in this retinal gene therapy firm, the Massachusetts-based company gains assets and synergy. In a March 4 BTIG research note, analyst Thomas Shrader reported that Biogen Inc. (BIIB:NASDAQ) entered into an agreement to acquire Nightstar Therapeutics Pl...
Streetwise Reports | March 7, 2019 |

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. In a May 13 research note, BTIG analyst Thomas Shrader reported that Gritstone Oncology Inc.'s (GRTS:NASDAQ) lead clinical programs, GRANITE and SL...
Streetwise Reports | May 27, 2019 |

The Third World Is Imploding: An Argument for Investment in Gold

Jayant Bhandair the founder of Capitalism and Morality sits down with Maurice Jackson to discuss the implosion of third world countries, precious metals, junior mining speculations, and philosophy. Mr. Bhandari is one of the most respected names in the natural resources sp...
Maurice Jackson | July 24, 2019 |

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...
Streetwise Reports | September 5, 2019 |

U.S. Biotech Rolls Out New Brachytherapy Delivery Tool Used for Prostate Cancer

The system, target markets and the marketing campaign for it are discussed in a Dawson James Securities report. In a Sept. 26 research note, Dawson James Securities analyst Jason Kolbert reported that IsoRay Inc. (ISR:NYSE.MKT) launched a new marketing campaign call...
Streetwise Reports | October 1, 2019 |
1 2 3 4 5 6 7 8 9 10 ...